Inactive Instrument

Meda AB Share Price

Stocks

SE0000221723

Pharmaceuticals

End-of-day quote Nasdaq Stockholm
- ^SEK	-

20/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

Latest news: Meda AB

20/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE
02/06/16	Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	RE
09/03/16	Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	RE
11/02/16	Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	RE
15/01/16	Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	RE
14/07/14	AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	RE
12/07/14	Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
12/07/14	Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
15/05/14	Banks vie for fees as Nordic deal scene ignites	RE
06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
01/05/14	Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	RE

Press Releases: Meda AB

25/08/16	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
08/08/16	Meda : Delisting of Meda Aktiebolag (publ)	BU
05/08/16	MEDA: Notice to noteholders regarding change of control	BU
02/08/16	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
02/08/16	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU

More press releases

News in other languages: Meda AB

20/07/16	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions
15/07/16	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources
11/02/16	Cisco Systems : Wall Street ouvre en net recul
11/02/16	Wall Street ouvre en baisse, craintes sur la croissance mondiale
11/02/16	Meda : BOURSE-Meda s'envole de plus de 70% après son rachat par Mylan

Managers and Directors: Meda AB

Manager	Title	Age	Since
Lars Henrik Andreas Rejnus CEO	Chief Executive Officer	52	-
Mårten Österlund LAW	General Counsel	69	08/12/2014
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	64	31/12/2004

Director	Title	Age	Since
Colleen Ostrowski BRD	Director/Board Member	53	24/08/2016
Caroline Rebecca Louise Dixon BRD	Director/Board Member	58	24/08/2016
Lars Henrik Andreas Rejnus CHM	Chairman	52	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+1.26%	+6.61%	+41.12%	+135.59%	1,286B
	JOHNSON & JOHNSON	+0.79%	+3.45%	+46.35%	+93.56%	688B
	ABBVIE INC.	+0.20%	+1.28%	+27.01%	+112.80%	521B
	ROCHE HOLDING AG	-0.44%	+3.69%	+39.60%	+69.51%	386B
	MERCK & CO., INC.	+0.55%	+0.70%	+59.00%	+44.20%	364B
	NOVARTIS AG	-0.12%	+0.74%	+26.78%	+58.43%	302B
	ASTRAZENECA PLC	+0.37%	+0.37%	+3.62%	+36.44%	287B
	AMGEN INC.	-0.30%	+1.14%	+38.59%	+74.61%	252B
	GILEAD SCIENCES, INC.	+0.08%	+0.71%	+34.25%	+124.32%	208B
	Average	+0.27%	+2.08%	+35.15%	+83.27%	477B
	Weighted average by Cap.	+0.54%	+3.26%	+37.63%	+96.23%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company